Dindin, Cerilo C.

HRN: 25-63-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/10/2026
01/31/2026
IV
2.25g
Q8H
Shock Multifactorial
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines